Adial Pharmaceuticals Inc (ADIL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ADIL | AZN | AMGN | GILD | BMY |
| Company | Adial Pharmaceuticals Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 1.7200 | 187.67 | 350.76 | 139.76 | 57.79 |
| High | 1.7500 | 187.86 | 356.28 | 140.42 | 58.52 |
| Low | 1.7000 | 186.62 | 350.76 | 138.71 | 57.79 |
| Latest | 1.7700 | 187.48 | 356.73 | 139.53 | 58.53 |
| Change | +0.0800 | +1.70 | +8.30 | +1.42 | +1.14 |
| % Change | +4.73% | +0.92% | +2.38% | +1.03% | +1.99% |
| Volume | 4,419 | 186,355 | 147,373 | 534,276 | 719,165 |
| 20-Day Average Volume | 160,151 | 1,800,045 | 2,658,622 | 6,554,297 | 14,284,177 |
| Previous Close | 1.6900 | 185.78 | 348.43 | 138.11 | 57.39 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.9754 | 193.91 | 366.94 | 144.16 | 59.82 |
| 20-Day Raw Stochastic | 14.95% | 17.36% | 18.36% | 19.99% | 30.30% |
| 20-Day Relative Strength | 28.48 | 43.33 | 45.62 | 45.55 | 48.79 |
| Weighted Alpha | -84.18 | +27.54 | +19.19 | +27.65 | +8.32 |
| Today's Opinion | 100% Sell | 56% Buy | 56% Buy | 56% Buy | 56% Buy |
| Previous Opinion | 100% Sell | 40% Buy | 56% Buy | 56% Buy | 56% Buy |
| Last Month's Opinion | 100% Sell | 100% Buy | 100% Buy | 88% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.44% since 03/18/26 | -0.66% since 03/18/26 | +0.56% since 03/18/26 | -1.40% since 03/18/26 | -1.63% since 03/18/26 |
| Low | 1.6900 on 03/24/26 | 182.39 on 03/24/26 | 344.95 on 03/20/26 | 136.44 on 03/23/26 | 56.45 on 03/24/26 |
| High | 2.0800 on 03/20/26 | 189.79 on 03/19/26 | 356.32 on 03/19/26 | 142.09 on 03/19/26 | 59.64 on 03/19/26 |
| 1-Month | |||||
| %Chg | -30.02% since 02/25/26 | -9.05% since 02/25/26 | -8.03% since 02/25/26 | -5.31% since 02/25/26 | -4.73% since 02/25/26 |
| Low | 1.5400 on 03/09/26 | 182.39 on 03/24/26 | 344.95 on 03/20/26 | 136.44 on 03/23/26 | 56.45 on 03/24/26 |
| High | 2.6600 on 02/26/26 | 209.93 on 02/27/26 | 391.29 on 03/02/26 | 150.77 on 03/02/26 | 62.89 on 03/02/26 |
| 3-Month | |||||
| %Chg | -71.47% since 12/24/25 | +1.23% since 12/24/25 | +5.84% since 12/24/25 | +10.85% since 12/24/25 | +6.74% since 12/24/25 |
| Low | 1.5400 on 03/09/26 | 178.08 on 01/21/26 | 318.21 on 01/05/26 | 116.88 on 01/05/26 | 52.06 on 01/05/26 |
| High | 6.7475 on 01/05/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | -79.59% since 09/25/25 | +27.27% since 09/25/25 | +30.34% since 09/25/25 | +25.51% since 09/25/25 | +34.53% since 09/25/25 |
| Low | 1.5400 on 03/09/26 | 146.66 on 09/26/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 42.52 on 10/29/25 |
| High | 10.7500 on 10/09/25 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,413 | 288,127,680 | 187,827,456 | 171,425,184 | 116,873,240 |
| Shares Outstanding, K | 1,428 | 1,550,908 | 539,068 | 1,241,222 | 2,036,474 |
| Annual Sales | 0 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -7,980,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 0 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | -2,000,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | 1.31 | 0.32 | 0.45 | 0.37 | 0.26 |
| Per-Share Information | |||||
| Most Recent Earnings | -2.00 on 11/13/25 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 05/13/26 | 05/05/26 | 05/07/26 | 04/23/26 | 04/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | 0.630 on 01/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 20.09 | 16.01 | 16.85 | 9.27 |